Does CLINDAMYCIN Cause Second primary malignancy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with CLINDAMYCIN (XACIATO). This represents 0.0% of all adverse event reports for CLINDAMYCIN.
5
Reports of Second primary malignancy with CLINDAMYCIN
0.0%
of all CLINDAMYCIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Second primary malignancy From CLINDAMYCIN?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLINDAMYCIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CLINDAMYCIN Cause?
Drug hypersensitivity (3,900)
Drug ineffective (1,894)
Rash (1,325)
Diarrhoea (1,206)
Off label use (901)
Nausea (803)
Pruritus (776)
Dyspnoea (607)
Condition aggravated (605)
Pyrexia (605)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which CLINDAMYCIN Alternatives Have Lower Second primary malignancy Risk?
CLINDAMYCIN vs CLINDAMYCIN\CLINDAMYCIN
CLINDAMYCIN vs CLINDAMYCIN\TRETINOIN
CLINDAMYCIN vs CLIOQUINOL
CLINDAMYCIN vs CLIOQUINOL\FLUMETHASONE
CLINDAMYCIN vs CLOBAZAM